{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:37:58Z","timestamp":1780627078875,"version":"3.54.1"},"reference-count":29,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03V0641"],"award-info":[{"award-number":["03V0641"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GI1010A"],"award-info":[{"award-number":["01GI1010A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ED1203H"],"award-info":[{"award-number":["01ED1203H"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00008","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T06:15:09Z","timestamp":1454048109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay"],"prefix":"10.3389","volume":"10","author":[{"given":"Katja","family":"K\u00fchbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"H\u00fclsemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Kravchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kulawik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Linnartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luriano","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Willbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Willbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bannach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e36620","DOI":"10.1371\/journal.pone.0036620","article-title":"Detection of prion protein particles in blood plasma of scrapie infected sheep","volume":"7","author":"Bannach","year":"2012","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B"},{"key":"B4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.vetmic.2007.04.001","article-title":"Counting of single prion particles bound to a capture-antibody surface (surface-FIDA)","volume":"123","author":"Birkmann","year":"2007","journal-title":"Vet. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ab.2012.09.014","article-title":"Amyloid-\u03b2 oligomer detection by ELISA in cerebrospinal fluid and brain tissue","volume":"433","author":"Bruggink","year":"2013","journal-title":"Anal. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2004","journal-title":"Nat. Neurosci."},{"key":"B9","author":"Crossbeta Biosciences","year":"2015","journal-title":"Crossbeta Oligomer Publications"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1096\/fj.09-150359","article-title":"High-molecular-weight \u03b2-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients","volume":"24","author":"Fukumoto","year":"2010","journal-title":"FASEB J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bbrc.2007.10.085","article-title":"Single particle detection of Abeta aggregates associated with Alzheimer's disease","volume":"364","author":"Funke","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/rej.2009.0925","article-title":"Single-particle detection system for A\u03b2 aggregates: adaptation of surface-fluorescence intensity distribution analysis to laser scanning microscopy","volume":"13","author":"Funke","year":"2010","journal-title":"Rejuvenation Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","article-title":"Anti-a\u03b2 therapeutics in Alzheimer's disease: the need for a paradigm shift","volume":"69","author":"Golde","year":"2011","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e66381","DOI":"10.1371\/journal.pone.0066381","article-title":"Evaluating amyloid-\u03b2 oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease","volume":"8","author":"H\u00f6ltt\u00e4","year":"2013","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","article-title":"Identifying and validating biomarkers for Alzheimer's disease","volume":"29","author":"Humpel","year":"2011","journal-title":"Trends Biotechnol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.colsurfb.2009.02.011","article-title":"Optimized straight forward procedure for covalent surface immobilization of different biomolecules for single molecule applications","volume":"71","author":"Janissen","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B19","doi-asserted-by":"publisher","first-page":"hzu002","DOI":"10.1093\/biohorizons\/hzu002","article-title":"An effective treatment for Alzheimer's disease must consider both amyloid and tau","volume":"7","author":"Lansdall","year":"2014","journal-title":"Biosci. Horizons"},{"key":"B20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-\u03b2 protein assembly in the brain impairs memory","volume":"440","author":"Lesn\u00e9","year":"2006","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"B23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer's disease - current concepts","volume":"8","author":"Ros\u00e9n","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"B24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3233\/JAD-2012-120211","article-title":"The load of amyloid-\u03b2 oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients","volume":"31","author":"Sancesario","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2007-11114","article-title":"Detection of amyloid-\u03b2 oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer","volume":"11","author":"Santos","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1523\/JNEUROSCI.1675-13.2014","article-title":"A sensitive A\u03b2 oligomer assay discriminates alzheimer's and aged control cerebrospinal fluid","volume":"34","author":"Savage","year":"2014","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased \u03b2-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3233\/JAD-122047","article-title":"The amyloid-\u03b2 oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease","volume":"34","author":"Wang-Dietrich","year":"2013","journal-title":"J. Alzheimers Dis."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T01:31:07Z","timestamp":1718328667000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fnins.2016.00008\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":29,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00008","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}